Influenza

Join Clinical Trials for Influenza (Flu)

Join Clinical Trials for Influenza (Flu)

General Purpose: Anyone who has ever had the flu knows that it can be a scary illness. Although sometimes its symptoms can be mild and impactful for only a few days, at other times it can be severe, and even deadly.

Fortunately, research pertaining to the viruses that cause the flu has provided valuable insight into their behavior both in the environment around us as well as within our bodies; however, the viruses continue to change, or mutate, making current vaccination all the more important, and driving the need for continued research to keep pace with this ever-changing entity.

As such, flu-related research focuses on a multitude of topics, including monitoring the viruses as they spread locally, nationally, and globally, evaluating the effectiveness of various flu vaccines, focusing on issues specific to high-risk populations (i.e., pregnant women, children, and the elderly), and new methods to prevent and treat infections.

Continued … Influenza Clinical Trials (Click to Open)

Join Clinical Trials for Influenza (Flu)

Influenza Clinical Trials

What Will Clinical Trials for Influenza Be Like?

When participating in Clinical Trials for Influenza, a few common tests and procedures may be involved; however, the ultimate design of the particular study will determine which Influenza Clinical Trialsspecific procedures you will undergo.

On a basic level, flu-related research studies might require multiple blood tests to detect the presence of the flu virus and changing levels of the virus in response to treatments. Others may involve the use of vaccinations followed by short-term monitoring (i.e., throughout the duration of a normal flu season).

Some studies may evaluate the effectiveness of various preventive measures, such as frequent hand washing, disinfecting, wearing of respiratory masks, and the use of vitamin supplements to boost the immune system.

Typical Flu Clinical Trial Protocol:

Research related to the flu is widespread and deep. Specific examples might include the following types of studies:

  • A study designed to investigate methods to refine diagnostic tools for the flu so that individual flu strains (i.e., viruses) can be identified quicker and more accurately. Studies such as these are especially important in light of concerns of a potential global flu outbreak.
  • Studies designed to develop new anti-viral medications to treat the flu.
  • A trial designed to determine the effectiveness of specific drug combinations at treating the flu.
  • A trial designed to determine how accurately certain drugs target specific portions of the flu virus, which can help to prevent drug resistance as well as uncover reasons why certain flu viruses become resistant to common treatments.
  • A study designed to evaluate the effectiveness of a vaccine targeted toward newly emerging flu viruses.
  • A study designed to evaluate the effectiveness of flu vaccines in special populations, such as children, the elderly, and individuals with chronic conditions like diabetes or cancer.

Suggested Search Terms:

“influenza vaccine,” “influenza pregnancy,” “influenza pregnancy,” “influenza elderly,” “influenza treatment,” and “influenza prevention.” 

Current Search Term:

“Influenza”



Cohort Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine


Condition:   Influenza
Intervention:   Biological: Butantan Fragmented Inactivated Trivalent Influenza Vaccine
Sponsor:   Butantan Institute
Completed - verified June 2016


Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza


Condition:   Influenza
Interventions:   Drug: Nitazoxanide;   Drug: Placebo
Sponsor:   Romark Laboratories L.C.
Completed - verified August 2016


Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age


Condition:   Influenza
Interventions:   Biological: Flublok Quadrivalent Influenza Vaccine;   Biological: Inactivated Influenza Vaccine
Sponsor:   Protein Sciences Corporation
Completed - verified October 2016


Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza


Condition:   Influenza
Interventions:   Drug: Nitazoxanide;   Drug: Oseltamivir;   Drug: Placebo Oral Tablet;   Drug: Placebo Oral Capsule
Sponsor:   Romark Laboratories L.C.
Completed - verified February 2017


The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated) (Children Forms of Drug)


Condition:   Influenza
Interventions:   Biological: Influenza Virus Vaccine(no Preservative );   Biological: Influenza Virus Vaccine(contains Preservative)
Sponsors:   Chinese Academy of Medical Sciences;   Hebei CDC ,China
Completed - verified July 2016


The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated)


Condition:   Influenza
Interventions:   Biological: Influenza Virus Vaccine;   Biological: Influenza Virus Vaccine(contains Preservative)
Sponsors:   Chinese Academy of Medical Sciences;   Hebei CDC ,China
Completed - verified July 2016


A Study to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine in Children


Condition:   Influenza
Interventions:   Biological: FluLaval® Quadrivalent;   Biological: Havrix™
Sponsor:   GlaxoSmithKline
Completed - verified August 2016


Safety and Immunogenicity Study of GSK Biologicals' Seasonal Influenza Candidate Vaccine (GSK2321138A)


Condition:   Influenza
Interventions:   Biological: Influenza vaccine GSK2321138A;   Biological: FluarixTM;   Biological: Influenza vaccine GSK2604409A
Sponsor:   GlaxoSmithKline
Completed - verified February 2017


A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Children


Condition:   Influenza
Interventions:   Biological: Quadrivalent seasonal influenza vaccine GSK2282512A;   Biological: Fluarix™ VB;   Biological: Fluarix™ YB;   Biological: Quadrivalent seasonal influenza vaccine GSK2282512A
Sponsor:   GlaxoSmithKline
Completed - verified September 2016


A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults


Condition:   Influenza
Interventions:   Biological: Quadrivalent seasonal influenza vaccine GSK2282512A;   Biological: FluLavalTM-VB;   Biological: FluLavalTM-YB
Sponsor:   GlaxoSmithKline
Completed - verified September 2016


Immunogenicity and Safety Study of GSK Biologicals' Influenza Vaccine When Administered in Children


Condition:   Influenza
Interventions:   Biological: Influenza vaccine GSK2321138A;   Biological: FluarixTM;   Biological: Influenza vaccine GSK2604409A
Sponsor:   GlaxoSmithKline
Completed - verified March 2017


Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1)


Condition:   Influenza
Intervention:   Biological: Influenza investigational vaccine GSK2340274A
Sponsor:   GlaxoSmithKline
Completed - verified March 2017


Study to Evaluate Immunological Equivalence Between Two Investigational Influenza Vaccines in Adults (H1N1)


Condition:   Influenza
Interventions:   Biological: Influenza vaccine GSK2340272A;   Biological: Influenza vaccine GSK2340274A
Sponsor:   GlaxoSmithKline
Completed - verified January 2017


Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1)


Condition:   Influenza
Interventions:   Biological: Pandemrix (GSK investigational influenza GSK2340272A vaccine);   Biological: Fluarix™;   Biological: Placebo
Sponsor:   GlaxoSmithKline
Completed - verified January 2017


Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults


Condition:   Influenza
Interventions:   Biological: GSK investigational vaccine GSK2340272A;   Biological: GSK investigational vaccine GSK2340272A
Sponsor:   GlaxoSmithKline
Completed - verified January 2017


Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults


Condition:   Influenza
Interventions:   Biological: GSK investigational vaccine GSK2340272A;   Biological: GSK investigational vaccine GSK2340269A
Sponsor:   GlaxoSmithKline
Completed - verified January 2017


Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine for the Elderly


Condition:   Influenza
Interventions:   Biological: GSK investigational FluNG vaccine GSK2186877A, aged lot;   Biological: GSK investigational FluNG vaccine GSK2186877A, fresh lot
Sponsor:   GlaxoSmithKline
Completed - verified October 2016


A Study for Evaluation of GSK Biologicals' Pandemic Influenza Vaccine.


Condition:   Influenza
Interventions:   Biological: GSK1562902A;   Biological: GSK1562902A
Sponsor:   GlaxoSmithKline
Completed - verified October 2016


Non-inferiority Study of GSK Biologicals' Influenza Vaccine GSK576389A Using Different Formulations


Condition:   Influenza
Interventions:   Biological: Thiomersal-free FluAS25 adjuvanted vaccine (GSK576389A);   Biological: Thiomersal reduced FluAS25 adjuvanted vaccine (GSK576389A)
Sponsor:   GlaxoSmithKline
Completed - verified November 2016


Revaccination With Influenza Vaccine GSK1247446A


Condition:   Influenza
Interventions:   Biological: Influenza Vaccine GSK1247446A;   Biological: Fluarix™
Sponsor:   GlaxoSmithKline
Completed - verified November 2016


Study to Evaluate an Influenza Vaccine Candidate


Condition:   Influenza
Interventions:   Biological: Influenza Vaccine GSK1247446A - 4 different formulations;   Biological: Fluarix™
Sponsor:   GlaxoSmithKline
Completed - verified November 2016


Immunogenicity of a Surface Antigen, Inactivated Influenza Vaccine Formulation 2007-2008


Condition:   Influenza
Intervention:   Biological: Surface antigen inactivated influenza vaccine
Sponsor:   Novartis Vaccines
Completed - verified November 2011


Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults


Condition:   Influenza
Intervention:   Biological: Influenza Vaccine GSK1562902A - 6 different formulations
Sponsor:   GlaxoSmithKline
Completed - verified October 2016


A Study to Demonstrate the Efficacy of GSK Biologicals' Influenza Vaccine in Adults


Condition:   Influenza
Intervention:   Biological: Fluarix vaccine
Sponsor:   GlaxoSmithKline
Completed - verified March 2017


Study to Evaluate an Influenza Vaccine Candidate


Condition:   Influenza
Interventions:   Biological: Candidate Influenza Vaccine GSK1247446A - 2 different formulations;   Biological: FluarixTM
Sponsor:   GlaxoSmithKline
Completed - verified September 2016

Refine Your Search Advanced Search